1. Cancer statistics, 2022
2. Key statistics for prostate cancer; [updated January 12, 2022]. Available from: https://www.cancer.org/cancer/prostate-cancer/about/key-statistics.html. Accessed March 31, 2022.
3. Meta-Analysis Evaluating the Impact of Site of Metastasis on Overall Survival in Men With Castration-Resistant Prostate Cancer
4. The genomic landscape of metastatic castration-resistant prostate cancers reveals multiple distinct genotypes with potential clinical impact
5. FDA approves olaparib for HRR gene-mutated metastatic castration-resistant prostate cancer; 2020 [updated May 20, 2020]. Available from: https://www.fda.gov/drugs/resources-information-approved-drugs/fda-approves-olaparib-hrr-gene-mutated-metastatic-castration-resistant-prostate-cancer. Accessed April 1, 2022.